Molecular Methods Show PCV Vaccine May Reduce Colony Density, Not Acquisition
The PCV-13 demonstrated an association with the detection of low-density colonization and resulted in vaccine efficacy against colonization acquisition.
All articles by Bradley van Paridon
Hospital Staff Mask Protocols Reduce Nosocomial Influenza Transmission
The “Masks Save Lives” campaign is highly effective in preventing nosocomial influenza infection in clinical settings.
Accuracy of Rapid MALDI-TOF Bacterial Identification for Bloodstream Infections
The MALDI-TOF assay demonstrated accuracy in the rapid identification of the most commonly isolated strains of bacterial colonies isolated from positive blood cultures.
Histoplasmosis-Related Healthcare Use, Diagnosis, and Treatment in the US
Histoplasmosis is associated with a wide spectrum of illness and a substantial burden for some patients.
Ceftolozane/Tazobactam Noninferior to Meropenem for Nosocomial Pneumonia
A combination dose of ceftolozane/tazobactam is noninferior to meropenem for treating nosocomial pneumonia.
First Clinical Development Candidate of Cidara’s Influenza Program Announced
Data supporting the selection of the antiviral conjugate CB-012 as Cidara Therapeutics Incorporated’s first clinical development candidate from the company’s influenza program.
Rifapentine Plus Isoniazid Noninferior to Isoniazid in HIV-Related TB
For prevention of TB in people with HIV, a single month regimen of rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone.
Antibody Response to Egg- and Cell-Grown Influenza A
Adults who received the flu vaccine in 2017 to 2018 had higher antibody titers against the egg-adapted vaccine and lower titers against circulating virus.
Effects of Sequential Influenza A Vaccination on Antibody Waning
Postvaccination antibody titers against influenza A similar across successive vaccinations but efficacy wanes with vaccine rates.
Machine Learning Model for Early Sepsis Risk Stratification
A new sepsis screening tool developed using machine learning was timelier and more discriminating than several benchmark screening tools.
